BPDE-DNA Antibodies

Santa Cruz Biotechnology features a diverse variety of BPDE-DNA monoclonal antibodies for detecting and analyzing DNA adducts formed by benzo[a]pyrene diol epoxide (BPDE). BPDE-DNA monoclonal antibodies support multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BPDE is a potent carcinogen that interacts with DNA, leading to the formation of adducts that can result in mutations and contribute to cancer development. Understanding the formation and repair of BPDE-DNA adducts is crucial for elucidating the mechanisms of chemical carcinogenesis and assessing the impact of environmental pollutants on human health. The study of BPDE-DNA interactions is essential for advancing cancer research and developing potential therapeutic strategies. BPDE-DNA monoclonal antibodies enable precise detection and quantification of DNA damage caused by environmental exposures. Investigating BPDE-DNA modifications helps reveal cellular responses to carcinogenic compounds. Research utilizing BPDE-DNA monoclonal antibodies from Santa Cruz Biotechnology continues to advance scientific understanding of chemical carcinogenesis and environmental health impacts.